Search
Invitrogen
Candesartan Recombinant Mouse Monoclonal Antibody (6G10)
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promotions']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.viewpromo']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promocode']}}: {{promo.promoCode}} {{promo.promoTitle}} {{promo.promoDescription}}. {{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.learnmore']}}
Additional Information:
{{banner.description}}
图: 1 / 1
Candesartan Antibody (MA566600) in SDS-PAGE
SDS-PAGE characterization of Candesartan under reducing conditions. Lane M: Protein marker (kDa); Lane CDT: Purified Candesartan Recombinant Monoclonal (Product # MA566600). Candesartan showing heavy chain (~50 kDa) and light chain (~25 kDa). Gels were stained with Coomassie Brilliant Blue R-671.
Please note: We are reviewing Western blot images included in the antibody testing data in our catalog, including those provided by third parties. Unless expressly labeled or annotated as “raw-unedited”, Western blot images included in the antibody testing data in our catalog may have been edited, optimized or otherwise adjusted for presentation.
产品信息
MA566600
产品规格
种属反应
Chemical
宿主/亚型
Mouse
/ IgG
Expression System
CHO cells
分类
Recombinant Monoclonal
类型
Antibody
克隆号
6G10
抗原
Conjugate of CDT hapten and KLH.
偶联物
Unconjugated
Unconjugated
Unconjugated
形式
Liquid
浓度
5.9 mg/mL
规格
200 µg
纯化类型
Protein G
保存液
PBS
内含物
0.09% sodium azide
保存条件
-20°C
运输条件
Ambient (domestic); Wet ice (international)
RRID
靶标信息
Candesartan is an angiotensin II receptor antagonist that functions by binding to the AT1 receptor, thereby preventing angiotensin II from exerting its vasoconstrictive and aldosterone-secreting effects. It is commonly used in the treatment of hypertension and is available as a prodrug, candesartan cilexetil, which is metabolized into its active form in the body. The pharmacokinetic parameters such as C max, AUC 0-t, and AUC 0-infinity have been studied to ensure bioequivalence in various formulations. Candesartan's dosage can be individualized, typically ranging from 4 to 32 mg daily. The development of candesartan biosimilars involves ensuring these pharmacokinetic parameters fall within the acceptable range to maintain efficacy and safety. This drug is part of a broader category of angiotensin-receptor blockers (ARBs) and has been the subject of systematic approaches to prodrug development to enhance its therapeutic profile.
仅用于科研。不用于诊断过程。未经明确授权不得转售。
篇参考文献 (0)
您是否在文献中引用过该产品？请点击下方按钮邮件告知我们。
Disclaimer
Clicking the images or links will redirect you to a website hosted by BenchSci that provides third-party scientific content. Neither the content nor the BenchSci technology and processes for selection have been evaluated by us; we are providing them as-is and without warranty of any kind, including for use or application of the Thermo Fisher Scientific products presented.
